Recent Finacing
Recent Raise
Capella Bioscience is a London-based biotech that uses proprietary discovery platforms to develop monoclonal antibody therapeutics targeting oncology and autoimmune disease, advancing programs toward clinical evaluation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors